A clinical trial for a diabetes device is a structured research study where medical companies and academic institutions test new or improved equipment designed to help manage diabetes. These aren't consumer products you can buy at a pharmacy yet. Instead, they're devices in various stages of development—sometimes brand new, sometimes existing devices being tested for new uses or in new patient populations.
Learn How to Grow Sweet Corn at Home →
The devices being tested fall into several categories. Continuous glucose monitors (CGMs) that track blood sugar in real-time throughout the day represent one major area. Insulin pumps—machines that deliver insulin automatically—are another. Then there are newer technologies like artificial pancreas systems that combine glucose monitoring with automatic insulin delivery, requiring less manual input from the person using them. Some trials test smartphone apps that work alongside these physical devices to help users track patterns and manage their condition more effectively.
The key distinction between a clinical trial and a finished product is the stage of proof. When a device enters a clinical trial, researchers haven't yet confirmed that it works as intended across many different people in real-world conditions. That's precisely what the trial determines. A company might have strong laboratory data showing a prototype works, but they need to test it with actual patients—people with different body types, different diabetes management styles, different daily routines—to understand how it truly performs.
Most diabetes device trials run between six months and several years, depending on what the device does and what questions researchers need to answer. Some trials might involve just 20 to 50 participants. Others, particularly those testing devices with significant safety considerations, might include hundreds of people across multiple hospital and clinic locations.
Practical takeaway: Understanding that a clinical trial is a research study—not a way to get a free device permanently, and not a guarantee that the device will work for you—helps you evaluate whether participating might actually fit your life and needs.
The Food and Drug Administration (FDA) oversees diabetes devices in the United States and sets rules about how they must be tested before reaching the market. These rules directly shape what trials exist and how long they run. Understanding the FDA's process helps explain why some devices seem to take years to become available while others move faster.
Learn About Treating Pustules at Home and Professional Options →
Devices follow one of two main pathways through FDA review. The first is the 510(k) pathway, typically used for devices similar to ones already on the market. A company demonstrates that their new device works about as well as an existing approved device. This process tends to be shorter—sometimes taking months rather than years—because the FDA already has a baseline for comparison. Many incremental improvements to existing glucose monitors or insulin pumps use this pathway.
The second pathway is Premarket Approval (PMA), used for novel devices that represent a significant new technology or serve a new purpose. An artificial pancreas system, for example, likely goes through PMA because it's doing something meaningfully different from previous devices—automating decisions that previously required human judgment. PMA requires more extensive clinical trial data because the FDA needs stronger proof that the device is safe and effective when used the way the manufacturer intends.
There's also a third category: de novo classification, used when a device is genuinely new and doesn't fit existing categories. This creates its own classification while typically requiring clinical trial data to establish safety and effectiveness.
Between these pathways, you'll see different types of trials advertising for participants. A 510(k) trial might focus on confirming that accuracy levels match existing devices. A PMA trial might dig deeper into long-term safety data, how users interact with the device in their actual lives, and whether it delivers the promised benefits over months of real-world use.
Practical takeaway: When you encounter a diabetes device trial, knowing which FDA pathway it follows tells you roughly how comprehensive the testing is and what stage the device is at—from "similar to existing options" to "completely new technology."
Several reliable resources maintain active lists of diabetes device trials recruiting participants. These databases are searchable and updated regularly, though the information quality and detail varies by source.
Free Guide to Finding Car Air Conditioning Repair Shops →
ClinicalTrials.gov is the official U.S. government database run by the National Library of Medicine. It contains information on tens of thousands of trials across all medical conditions. You can search for "diabetes device" or "continuous glucose monitor" or "artificial pancreas" and filter by location, study status, and other criteria. Each trial listing includes a description of what researchers are testing, basic criteria about who might participate, contact information for the research site, and expected enrollment numbers. The database isn't always perfectly up-to-date—some trials listed as "recruiting" might have actually closed—but it's comprehensive and free to search.
The American Diabetes Association (ADA) maintains a section on their website highlighting clinical trials related to diabetes management. Their listings tend to be more curated and include context about what each trial is testing and why it matters. The ADA also sends information about new trials through their email newsletters if you sign up.
Individual device manufacturers often list trials on their own websites. If you're interested in a specific brand of glucose monitor or insulin pump, checking their research section can reveal if they're currently testing new versions or new features. Some manufacturers have online forms where you can enter your information to be contacted if a relevant trial opens in your area.
Medical centers and diabetes research programs frequently post information about their trials on their websites and through their patient communication channels. If you receive care at a large hospital system or specialized diabetes clinic, asking your healthcare provider directly about ongoing trials can connect you with opportunities you might not find through online searching.
Professional conferences and published research articles sometimes highlight upcoming trials. The journal Diabetes Care and Diabetes Technology & Therapeutics regularly publish trial results and announcements about new studies being launched.
Practical takeaway: Start with ClinicalTrials.gov for the broadest search, then supplement with manufacturer websites and your own healthcare provider if you want information focused on specific devices or locations.
The actual experience of participating in a diabetes device trial varies widely depending on the trial's goals, but most follow a common structure worth understanding before considering participation.
Your Free Guide to AARP Travel Insurance Plans →
Most trials begin with a screening visit where researchers confirm you have diabetes and that your current management approach is stable. They'll review your medical history, current medications, and how your diabetes has been controlled recently. This screening determines whether you truly fit the trial's parameters. For instance, a trial testing a new continuous glucose monitor for people with type 1 diabetes might require that participants have had diabetes for at least one year and that their blood sugar control falls within a certain range.
If you're accepted into the trial, you'll attend a baseline visit where researchers collect detailed information about your current diabetes management routine. They'll likely run blood work to establish a starting point for comparison later. Then comes the device training—learning how to use the experimental device or the new version of a familiar device. This training period is crucial and typically requires several hours or multiple sessions. Researchers need to ensure you understand how to operate the device correctly and how to report problems or unexpected results.
During the active trial period, you'll use the device according to the study protocol. For a continuous glucose monitor trial, this might mean wearing the sensor for weeks or months and recording readings at specific times or whenever you eat. For an insulin pump trial, you might adjust your pump settings based on feedback from researchers as they monitor your blood sugar patterns. Some trials ask you to keep detailed logs of what you eat and your physical activity so researchers can correlate these with the device's readings.
You'll have regular follow-up visits—sometimes monthly, sometimes more frequently—where researchers check the device's function, download the data it's collected, and assess how you're doing physically and emotionally. Blood work might be repeated to measure your A1C (average blood sugar over three months) and other markers. Researchers often ask structured questions about whether the device is easy to use, whether it fits into your daily routine, and whether you've experienced any unexpected effects or problems.
Importantly, trial protocols typically include safety monitoring. If the device or the study medication associated with it shows signs of causing harm, the trial might be adjusted or stopped. There's usually a safety monitoring board—independent doctors who aren't directly involved in the trial—reviewing ongoing data to watch for problems.
Practical takeaway: Participating in a diabetes device trial requires active engagement over weeks or months, including visits, training, daily use of an unfamiliar device, and detailed record-keeping—
This guide is for general information only and is not medical, financial, legal, or other professional advice. For decisions specific to your situation, consult a qualified professional. See our Editorial Policy.